Health
Astrazeneca’s New COVID Antibody Drug Promises Instant Coronavirus Immunity Enters Phase 3 Trials – Tech Times
If proven effective, this would be another breakthrough from Astrazeneca.
Scientists from the University College London Hospitals NHS Trust (UCLH) are studying the possibility of providing instant long-term immunity to patients who are at higher risk. The new COVID antibody drug developed by pharmaceutical giant Astrazeneca promises to give instant protection against SARS-COV-2, the virus causing the deadly COVID-19 that transformed the world in 2020.
If proven effective, this would be another breakthrough from Astrazeneca, which is still waiting for the approval from…
Continue Reading